Subscribe Become an Author Add Company Sign Up Log In

AI in Drug Discovery


On the Cutting-Edge of the Fight Against the Pandemic

   by adMare BioInnovations    85

Variational AI Receives Support from the Digital Technology Supercluster for Repurposing of Drugs for COVID-19

Vancouver, British Columbia [April 21, 2020] – Variational AI Inc. is pleased to announce a new project using their novel artificial intelligence technology to rapidly identify existing drugs with a high probability of being efficacious in combatting COVID-19.

Annual Summit on Drug Discovery Chemistry

   by BiopharmaTrend    378
Annual Summit on Drug Discovery Chemistry

The Annual Summit on Drug Discovery Chemistry primarily works on the theme “Scientific Congress on pursuit of wisdom in Drug Discovery Chemistry”. The main outcomes of the conference are sharing the insights, experiences and strategies of experts in drug discovery, discover the latest trends in drug chemistry, know the growing demand for drug discovery and pharmaceutical chemistry, find out how progress is being made in scientific formulation in practice and discover the tried and tested bio availability routes.

7th Annual Peptides & Oligonucleotides Congress

   by BiopharmaTrend    320
7th Annual Peptides & Oligonucleotides Congress

With major developments in the peptide field and with more and more peptide and oligonucleotide therapeutics entering clinical trials, the real promise of peptides and oligonucleotides is starting to be realised. Part of our Biologics Series, this event will take you through the key stages of peptide development from peptide discovery through to formulation and delivery, manufacturing and synthesis, as well as oligonucleotide synthesis, chemistry, formulation, as well as therapeutics and manufacturing.

4th Annual Genome Editing USA Congress

   by BiopharmaTrend    301
4th Annual Genome Editing USA Congress

The congress will showcase the latest technologies, drugs and in vivo therapeutic solutions that are being produced by pioneers in the genome editing field. The congress will feature over 30 presentations in a comprehensive conference programme designed to provide an increased knowledge of current trends influencing gene editing research. Key speakers include Directors from Novartis, Pfizer, Harvard, MIT and more.